Peter Thiel, the co-founder of PayPal and a Facebook investor, is also interested in biotech, especially in companies that can methodically put their ideas into practice, writes Antonio Regalado at MIT's Technology Review. Too often, Thiel says, companies wind up spending a lot of money trying to come up with drugs that may not even work.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.